Topic: IMMUNE BIOSOLUTIONS
3 results were found.
Immune Biosolutions' immunotherapy product neutralizes 100% of SARS-CoV-2 variants of concern - January 11, 2022
Immune Biosolutions begins Phase I clinical trial stages for its inhaled immunotherapy treatment - October 20, 2021
Immune Biosolutions receives C$13.44m to develop its immunotherapy to treat COVID-19 and its variants - March 17, 2021